Note: The impact score shown here is equivalent to the average number of times documents published in a journal/conference in the past two years have been cited in the current year (i.e., Cites / Doc. (2 years)). It is based on Scopus data and can be a little higher or different compared to the impact factor (IF) produced by Journal Citation Report. Please refer to the Web of Science data source to check the exact journal impact factor ™ (Thomson Reuters) metric.
|Title||Current Vascular Pharmacology|
|Abbreviation||Curr. Vasc. Pharmacol.|
|Subject Area, Categories, Scope||Cardiology and Cardiovascular Medicine (Q2); Pharmacology (Q2)|
|SCImago Journal Rank (SJR)||0.806|
|Publisher||Bentham Science Publishers B.V.|
|Country||United Arab Emirates|
Vascular disease is the commonest cause of death in Westernized countries and its incidence is on the increase in developing countries. It follows that considerable research is directed at establishing effective treatment for acute vascular events. Long-term treatment has also received considerable attention. Furthermore, effective prevention, whether primary or secondary, is backed by the findings of several landmark trials. Vascular disease is a complex field with primary care physicians and nurse practitioners as well as several specialties involved.
Current Vascular Pharmacology publishes clinical and research-based reviews and debates to update all those concerned with the treatment of vascular disease, bridging the gap between clinical practice and ongoing research.
Current Vascular Pharmacology is a journal covering the technologies/fields/categories related to Cardiology and Cardiovascular Medicine (Q2); Pharmacology (Q2). It is published by Bentham Science Publishers B.V.. The overall rank of Current Vascular Pharmacology is 5984. According to SCImago Journal Rank (SJR), this journal is ranked 0.806. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come. SJR acts as an alternative to the Journal Impact Factor (or an average number of citations received in last 2 years). This journal has an h-index of 60. The best quartile for this journal is Q2.
The ISSN of Current Vascular Pharmacology journal is 15701611, 18756212. An International Standard Serial Number (ISSN) is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic. Current Vascular Pharmacology is cited by a total of 609 articles during the last 3 years (Preceding 2020).
The impact score (IS) 2020 of Current Vascular Pharmacology is 2.08, which is computed in 2021 as per its definition. Current Vascular Pharmacology IS is increased by a factor of 0.13 and approximate percentage change is 6.67% when compared to preceding year 2019, which shows a rising trend. The impact score (IS), also denoted as Journal impact score (JIS), of an academic journal is a measure of the yearly average number of citations to recent articles published in that journal. It is based on Scopus data.
IS 2020 of Current Vascular Pharmacology is 2.08. If the same upward trend persists, impact score of joule may rise in 2021 as well.
|Year||Impact Score (IS)|
Current Vascular Pharmacology has an h-index of 60. It means 60 articles of this journal have more than 60 number of citations. The h-index is a way of measuring the productivity and citation impact of the publications. The h-index is defined as the maximum value of h such that the given journal/author has published h papers that have each been cited at least h number of times.
The ISSN of Current Vascular Pharmacology is 15701611, 18756212. ISSN stands for International Standard Serial Number.
An ISSN is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic.
The overall rank of Current Vascular Pharmacology is 5984. According to SCImago Journal Rank (SJR), this journal is ranked 0.806. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come.
Current Vascular Pharmacology is published by Bentham Science Publishers B.V.. It's publishing house is located in United Arab Emirates. Coverage history of this journal is as following: 2003-2020. The organization or individual who handles the printing and distribution of printed or digital publications is known as Publisher.
Visit the official website of the journal/conference to check the further details about the call for papers.
The IS0 4 standard abbreviation of Current Vascular Pharmacology is Curr. Vasc. Pharmacol.. This abbreviation ('Curr. Vasc. Pharmacol.') is well recommended and approved for the purpose of indexing, abstraction, referencing and citing goals. It meets all the essential criteria of ISO 4 standard.
ISO 4 (International Organization for Standardization 4) is an international standard that defines a uniform and consistent system for abbreviating serial publication titles and journals.
If your research field is/are related to Cardiology and Cardiovascular Medicine (Q2); Pharmacology (Q2), then please visit the official website of this journal.
The acceptance rate/percentage of any academic journal/conference depends upon many parameters. Some of the critical parameters are listed below.
It is essential to understand that the acceptance rate/rejection rate of papers varies among journals. Some Journals considers all the manuscripts submissions as a basis of acceptance rate computation. On the other hand, few consider the only manuscripts sent for peer review or few even not bother about the accurate maintenance of total submissions. Hence, it can provide a rough estimation only.
The best way to find out the acceptance rate is to reach out to the associated editor or to check the official website of the Journal/Conference.
|Journal/Conference/Workshop/Book Title||Type||Ranking||Publisher||h-index||Impact Score|
|Der Pathologe||journal||21117||Springer Verlag||26||0.48|
|Tellus, Series B: Chemical and Physical Meteorology||journal||6914||Taylor and Francis Ltd.||103||2.05|
|Innovations in Clinical Neuroscience||journal||6768||Matrix Medical Communications||34||1.72|
|Journal of Law, Economics, and Organization||journal||1330||Oxford University Press||70||1.77|
|Motricite Cerebrale||journal||28530||Elsevier Masson||6||0.03|
|BMC Molecular Biology||journal||6441||BioMed Central Ltd.||73||2.65|
|IEEE Transactions on Human-Machine Systems||journal||5345||IEEE Systems, Man, and Cybernetics Society||123||4.52|
|Nutrition and Cancer||journal||7247||Routledge||117||2.61|
|Horticulture Environment and Biotechnology||journal||8948||Springer Science + Business Media||24||1.98|
|Year||Impact Score (IS)|